Last reviewed · How we verify
Aripiprazole and sertraline — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Aripiprazole and sertraline (Aripiprazole and sertraline) — Otsuka Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aripiprazole and sertraline TARGET | Aripiprazole and sertraline | Otsuka Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aripiprazole and sertraline CI watch — RSS
- Aripiprazole and sertraline CI watch — Atom
- Aripiprazole and sertraline CI watch — JSON
- Aripiprazole and sertraline alone — RSS
Cite this brief
Drug Landscape (2026). Aripiprazole and sertraline — Competitive Intelligence Brief. https://druglandscape.com/ci/aripiprazole-and-sertraline. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab